Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
X
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Ovid Therapeutics
OVID
$495M
| $870K | ﹤0.01% |
2,636,115
-472,666
| -15% | -$142K |
|
3777
Radware
RDWR
$1.2B
| $867K | ﹤0.01% |
29,463
| – | – |
|
3778
CVD Equipment Corp
CVV
$59.5M
| $866K | ﹤0.01% |
290,698
-2,531
| -0.9% | -$7.47K |
|
|
IGMS
3779
DELISTED
IGM Biosciences
IGMS
| $859K | ﹤0.01% |
767,154
-108,415
| -12% | -$132K |
|
|
GGRP
3780
Glimpse Group
GGRP
$18.7M
| $853K | ﹤0.01% |
627,000
+34,042
| +6% | +$43.5K |
|
3781
Intellinetics
INLX
$24.2M
| $852K | ﹤0.01% |
68,198
+36,788
| +117% | +$475K |
|
3782
Dyadic International
DYAI
$37.5M
| $852K | ﹤0.01% |
860,661
+46,318
| +6% | +$50.8K |
|
|
SOHO
3783
DELISTED
Sotherly Hotels
SOHO
| $845K | ﹤0.01% |
886,621
+196,634
| +28% | +$156K |
|
|
ARIS
3784
Aris Mining
ARIS
$3.52B
| $842K | ﹤0.01% |
125,059
+5,664
| +5% | +$33.6K |
|
|
EFXT
3785
Enerflex
EFXT
$2.46B
| $836K | ﹤0.01% |
105,919
-6,361
| -6% | -$45.5K |
|
|
DRUG
3786
Bright Minds Biosciences
DRUG
$796M
| $835K | ﹤0.01% |
+31,983
| New | +$959K |
|
3787
Avalo Therapeutics
AVTX
$989M
| $833K | ﹤0.01% |
166,941
| – | – |
|
3788
Laser Photonics
LASE
$57.2M
| $833K | ﹤0.01% |
309,555
+4,840
| +2% | +$12.7K |
|
3789
Comscore
SCOR
$109M
| $833K | ﹤0.01% |
172,729
| – | – |
|
|
ELEV
3790
DELISTED
Elevation Oncology
ELEV
| $828K | ﹤0.01% |
2,256,690
-328,530
| -13% | -$110K |
|
3791
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $824K | ﹤0.01% |
14,684
+4,299
| +41% | +$238K |
|
3792
Harvard Bioscience
HBIO
$28.1M
| $823K | ﹤0.01% |
185,389
-28,486
| -13% | -$119K |
|
|
AAUC
3793
Allied Gold Corp
AAUC
$2.7B
| $822K | ﹤0.01% |
+61,203
| New | +$865K |
|
3794
GameSquare
GAME
$37.6M
| $820K | ﹤0.01% |
943,668
+692,093
| +275% | +$507K |
|
|
YARW
3795
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
| $819K | ﹤0.01% |
9,926
+413
| +4% | +$26.8K |
|
|
LIMN
3796
Liminatus Pharma
LIMN
$7.12M
| $819K | ﹤0.01% |
+73,424
| New | +$824K |
|
3797
Kornit Digital
KRNT
$787M
| $817K | ﹤0.01% |
41,052
| – | – |
|
|
BSIN
3798
Big Sky Industrial
BSIN
$63.3M
| $817K | ﹤0.01% |
583,643
| – | – |
|
3799
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.98B
| $816K | ﹤0.01% |
6,606
-65
| -1% | -$7.65K |
|
3800
Passage Bio
PASG
$14.1M
| $816K | ﹤0.01% |
102,028
-1,549
| -1% | -$11.3K |
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 109, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 109 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.